Infectious Diseases 1408 - Infectious Disease Alert - Aug 01, 2010

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editors
Ellen Jo Baron, PhD, D(ABMM)
Professor Emerita
Stanford University School of Medicine
Director of Medical Affairs
Sunnyvale, CA

Brian G. Blackburn, MD
Clinical Assistant Professor
Division of Infectious and Geographic Medicine
Stanford University School of Medicine

Alan D Tice, MD, FACP
Infectious Disease Consultant
John A. Burns School of Medicine
University of Hawaii
Section Editor, Managed Care

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Hal B. Jenson, MD, FAAP
Professor of Pediatrics
Tufts University School of Medicine
Chief Academic Officer
Baystate Medical Center
Springfield, MA

Joseph F. John, Jr., MD, FACP
Associate Chief of Staff for Education
Ralph H. Johnson Veterans Administration Medical Center
Professor of Medicine
Medical University of South Carolina
Charleston, SC


  • Blood Culture-negative Endocarditis: What Can the Laboratory Bring to the Table?
  • Malaria Surveillance in the United States
  • Ivermectin and Malaria
  • Mitochondrial Toxicity of Ribavirin and HAART Correlates with Virological Response of HCV in HIV/HCV Co-infected Patients
  • Improved Immunogenicity of Pneumococcal Vaccine in HIV Patients with Toll-like Receptor Agonist Adjuvant
  • Breast-feeding Reduces Risk of Infectious Diseases
  • Cryptococcal Infection Has Taken a New Twist
  • Catching Dengue in Florida
  • Updates By Carol Kemper, MD, FACP


  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau for Merck, Pfizer, Wyeth, Ortho-McNeil (J&J), Schering-Plough, and Cubist, does research for the National Institute of Health, and is an advisory board member for Schering-Plough, Ortho-McNeil (J&J), and Cepheid. Peer Reviewer Timothy Jenkins, MD, Associate Editors Ellen Jo Baron, PhD, D(ABMM), Brian G. Blackburn, MD, Alan D. Tice, MD, FACP, Hal B. Jenson, MD, FAAP, and Joseph F. John, Jr., MD, report no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, serves as a consultant for Siemens Diagnostics and is on the speaker's bureau for GSK and Cubist. Updates Author Carol A. Kemper, MD, FACP, does research for GSK Pharmaceuticals, Abbott Laboratories, and Merck.

Copyright 2010 AHC Media. All rights reserved.